Cañis Parera Marta
Director · Spanish companies register · 2 companies
- Companies :
- 2 (2 current, 0 former)
- Linked companies :
- MD FASCIOPATHY SOLUTIONS GROUP S.L, RESIDENCIAL EL COLOME SOCIEDAD LIMITADA
Summary
Cañis Parera Marta appears in the Spanish commercial register as a director of 2 companies, all current. Currently Administrador Solidario of MD FASCIOPATHY SOLUTIONS GROUP S.L (Barcelona) since 13 December 2023, as well as in 1 other company. MD FASCIOPATHY SOLUTIONS GROUP S.L is based in Vic and operates in Actividades de medicina especializada (CNAE 8622) — Sociedades de responsabilidad limitada, an active company, incorporated on 20 December 2023, share capital of €3,000. The earliest registered mandate dates from 3 September 2014, at RESIDENCIAL EL COLOME SOCIEDAD LIMITADA; the most recent began on 13 December 2023. The offices held are Administrador Solidario and Administrador Único. The companies are registered in Barcelona and Tarragona. The boards of these companies also include Exposito Izquierdo Marta.
Offices held
Commercial registries
Barcelona · Tarragona
Companies · current (2)
Administrador Solidario since 13/12/2023
Active · Actividades de medicina especializada (CNAE 8622) · Vic · Sociedades de responsabilidad limitada · incorporated 20/12/2023 · capital €3,000 · 1 BORME filing
Corporate purpose: LA PRESTACION DE LA ACTIVIDAD PROPIA DEL EJERCICIO DE LA MECIDINA EN GENERAL Y EN TODAS SUS ESPECIALIZADES, COMO LA PRESTACION DE TODA CLASE DE SERVICIOS MEDICOS Y SOCIALES A PERSONAS CON O SIN DEPENDENCIA, ETC.
B56479041 · Barcelona
Administrador Único since 03/09/2014
Active · Bisbal del Penedes, La · Sociedad Limitada (SL) · 2 BORME filings
B43511419 · Tarragona
Timeline (2)
- 13/12/2023Appointed Administrador Solidario of MD FASCIOPATHY SOLUTIONS GROUP S.L · Barcelona
- 03/09/2014Appointed Administrador Único of RESIDENCIAL EL COLOME SOCIEDAD LIMITADA · Tarragona
Co-directors (1)
- Exposito Izquierdo Marta · Administrador Solidario
Network map
Identity matched by name · homonyms possible.